Ovidiu C Trifan

Author PubWeight™ 9.49^‹?›

Rank	Title	Journal	Year	PubWeight™‹?›
1	Role of prostaglandin E2-dependent angiogenic switch in cyclooxygenase 2-induced breast cancer progression.	Proc Natl Acad Sci U S A	2003	2.23
2	Potential involvement of the cyclooxygenase-2 pathway in the regulation of tumor-associated angiogenesis and growth in pancreatic cancer.	Mol Cancer Ther	2003	1.07
3	Biomarker analysis of neoadjuvant doxorubicin/cyclophosphamide followed by ixabepilone or Paclitaxel in early-stage breast cancer.	Clin Cancer Res	2013	1.01
4	Microsomal prostaglandin E synthase-1 regulates human glioma cell growth via prostaglandin E(2)-dependent activation of type II protein kinase A.	Mol Cancer Ther	2006	0.96
5	A retrospective analysis of cross-reacting cetuximab IgE antibody and its association with severe infusion reactions.	Cancer Med	2014	0.92
6	Randomized phase II study of ixabepilone or paclitaxel plus carboplatin in patients with non-small-cell lung cancer prospectively stratified by beta-3 tubulin status.	J Clin Oncol	2013	0.89
7	Validation of companion diagnostic for detection of mutations in codons 12 and 13 of the KRAS gene in patients with metastatic colorectal cancer: analysis of the NCIC CTG CO.17 trial.	Arch Pathol Lab Med	2012	0.87
8	COX-2 inhibitors as radiosensitizing agents for cancer therapy.	Am J Clin Oncol	2003	0.86
9	A phase 2 trial of ixabepilone plus cetuximab in first-line treatment of metastatic pancreatic cancer.	Gastrointest Cancer Res	2012	0.78